Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a note issued to investors on Saturday. The firm set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $7.00 price target on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Trading Down 1.4 %

AEMD stock opened at $0.67 on Friday. The stock has a market cap of $9.31 million, a P/E ratio of -0.24 and a beta of 1.61. Aethlon Medical has a twelve month low of $0.24 and a twelve month high of $2.10. The company’s 50 day moving average is $0.50 and its two-hundred day moving average is $0.43.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.